Abstract PO4-06-07: Efficacy and safety of futibatinib in patients with locally advanced/metastatic triple-negative breast cancer harboring FGFR2 gene amplification: final results from the phase 2, open-label FOENIX-MBC2 study
Year: 2024
Type: conference-abstract
Source: Cancer Research
Institutions: Harvard University, Dana-Farber Cancer Institute, The University of Texas Southwestern Medical Center, The University of Texas MD Anderson Cancer Center, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Sarah Cannon Research Institute, Centre Léon Bérard, University of Modena and Reggio Emilia, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco", Yale Cancer Center, Yale University, Taiho Oncology (United States), Institute of Cancer Research, Royal Marsden Hospital
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4396591101